Securities to be registered pursuant to Section 12(g) of the Act: None

INFORMATION REQUIRED IN REGISTRATION STATEMENT

The securities to be registered hereby consist of: 2.125% notes due 2026 of Walgreens Boots Alliance, Inc., a Delaware corporation (“WBA”), 2.875% notes due 2020 of WBA, and 3.600% notes due 2025 of WBA (collectively, the “Notes”), each issued pursuant to the indenture dated as of November 18, 2014 between WBA and Wells Fargo Bank, National Association, as trustee, (the “Indenture”). The form of each series of Notes are incorporated by reference to Exhibits 4.2, 4.3 and 4.4, respectively, hereto.

WBA hereby incorporates by reference the description of its securities to be registered hereunder contained in the Prospectus dated November 3, 2014 under “Description of Securities” and in the Prospectus Supplement dated November 10, 2014, under “Description of the Notes,” filed with the Securities and Exchange Commission (the “Commission”) on November 12, 2014 under Rule 424(b)(5) under the Securities Act of 1933, as amended (the “Act”), pursuant to a Registration Statement on Form S-3 (No. 333–198773), as amended, previously filed with the Commission under the Act.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.